What is the Difference Between NMO and MS?

🆚 Go to Comparative Table 🆚

Neuromyelitis optica (NMO) and multiple sclerosis (MS) are both immune system disorders that affect the nerves, but they have distinct differences in their characteristics and manifestations. Some key differences between NMO and MS include:

  1. Affected areas: NMO primarily affects the optic nerve and spinal cord, while MS can affect a wider range of brain areas.
  2. Severity of attacks: People with NMO have a higher likelihood of more severe attacks than those living with MS. The severity of MS attacks is less than NMO attacks, especially in the early stages of the disease.
  3. Disease progression: MS is a progressive condition, while NMO is not. In NMO, the cumulative decline develops during attacks, not in between them, whereas a person with MS can experience progression even without a true attack, resulting in additional disabilities or symptoms.
  4. Onset age: The age of onset differs between the two conditions, with NMO tending to strike later in life than MS.
  5. Visual symptoms: NMOSD usually affects only the optic nerve and spinal cord, while MS often affects other brain areas. Vision loss with MS usually affects one eye at a time, but NMO spectrum disorder may affect both eyes at the same time.
  6. Cognitive symptoms: With MS, changes in memory, reasoning, problem-solving, and depression are also common, while NMO primarily affects the optic nerve and spinal cord.
  7. Prevalence: MS is more common than NMO, with nearly 1 million people in the United States having MS, compared to about 250,000 cases of NMO worldwide, including around 4,000 in the United States.
  8. Geographical distribution: People with MS tend to be concentrated in areas farther from the equator, while NMO can be found in any climate.
  9. Diagnostic criteria: In NMO, spinal cord lesions tend to be centrally located, rarely extending to the surface of the cord, whereas in MS such lesions are usually located peripherally.

It is crucial to differentiate between NMO and MS to ensure proper treatment and care, as the two conditions have distinct characteristics and require different management strategies.

Comparative Table: NMO vs MS

Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) are both autoimmune demyelinating diseases that affect the central nervous system. Here is a table summarizing the differences between NMOSD and MS:

Feature NMOSD MS
Epidemiology Rarer, prevalence varies depending on the region More common, prevalence varies depending on the region
Age of Onset Average age of onset differs between the two conditions Average age of onset may be similar, but NMOSD tends to have more severe attacks
Severity of Attacks and Disease Progression People with NMO have a higher likelihood of more severe attacks than those living with MS MS is considered progressive, while NMO does not have the same pattern of progression
Diagnosis Testing for anti-aquaporin-4 (AQP4) autoantibodies can help distinguish NMOSD from MS MS diagnosis relies on MRI findings and other clinical assessments
Treatment Different disease-modifying treatments are used for NMOSD and MS, such as interferon-β, fingolimod, natalizumab, and alemtuzumab MS treatments may include disease-modifying therapies, corticosteroids, and other symptom-specific medications

Differentiating between NMOSD and MS is crucial for proper treatment and care. Researchers have been developing machine learning models to improve the accuracy of diagnosing these conditions, with some studies achieving accuracies of 74% to 84% depending on the modality used.